Establishment Labs Inc. (ESTA)

AI Score

Unlock

40.36

-0.28 (-0.69%)

At close: Mar 28, 2025, 3:59 PM

40.43

0.17%

After-hours: Mar 28, 2025, 04:33 PM EDT

-0.69% (1D)

Bid	36
Market Cap	1.16B
Revenue (ttm)	165.47M
Net Income (ttm)	-84.31M
EPS (ttm)	-3
PE Ratio (ttm)	-13.45
Forward PE	-17.19
Analyst	Buy

Ask	41.75
Volume	219,137
Avg. Volume (20D)	614,966
Open	40.33
Previous Close	40.64
Day's Range	38.75 - 41.33
52-Week Range	28.16 - 60.12
Beta	0.95

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as dis...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jul 19, 2018

Employees 1,018

Stock Exchange NASDAQ

Ticker Symbol ESTA

Website https://www.establishmentlabs.com

Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $52, which is an increase of 28.84% from the latest price.

Stock Forecasts

Next Earnings Release

Establishment Labs Inc. is scheduled to release its earnings on May 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+17.94%

Establishment Labs shares are trading higher after... Unlock content with Pro Subscription

2 months ago

-26.38%

Establishment Labs shares are trading lower after the company announced a CEO transition.

News

1 week ago · businesswire.com

Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

1 month ago · seekingalpha.com

Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call Transcript

Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Raj Denhoy - CFO Juan Chacón-Quirós - CEO Peter Caldini - President C...

1 month ago · zacks.com

Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Lags Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $0.79 per share a year ago.

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness in breast aesthetics and reconstructi...